The American Society of Clinical Oncology (ASCO) warns that Medicaid work requirements may hinder patients’ access to essential cancer care and reduce the already limited time physicians are able to spend with their patients. In a new position statement released today, ASCO also recommends that federal and state policymakers take specific steps to ensure that new Medicaid requirements will not harm patients with cancer.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO strongly opposes the Centers for Medicare & Medicaid Services (CMS) decision to allow Medicare Advantage plans to employ step therapy across physician-administered and self-administered drugs under Medicare Part B and Part D.
Representatives from ASCO and other medical specialty groups recently met with officials from the U.S. Department of Health and Human Services (HHS) to discuss the 2019 Medicare Physician Fee Schedule (MPFS). The meeting provided Administration officials with an opportunity to explain provisions in the 2019 MPFS proposed rule and for stakeholders to ask questions and express their concerns with the proposal.
Merit-based Incentive Payment System (MIPS) final score and performance feedback are now available for review on the Quality Payment Program website for physicians that participated in MIPS in 2017.
ASCO submitted a statement to the U.S. House of Representatives Energy and Commerce Committee in conjunction with a subcommittee hearing on implementation of the Merit-Based Incentive Payment System (MIPS) under the Medicare Access and CHIP Reauthorization Act (MACRA).
On July 25, the Centers for Medicare & Medicaid Services released its 2019 Hospital Outpatient Prospective Payment System proposed rule. Among other provisions, the proposal would extend 2018 reimbursement cuts to the 340B Drug Pricing Program to include currently excepted, off-site hospital-affiliated outpatient clinics.
The Centers for Medicare & Medicaid Services (CMS) released its proposed rule for 2019 Medicare physician reimbursement. CMS estimates that in 2019, the overall impact for the hematology/oncology specialty will be a 4 percent reduction in reimbursement and a 2 percent reimbursement reduction for radiation/oncology. These overall impacts reflect statutory adjustment factors, related to the Medicare Access and CHIP Reauthorization Act and Relative Value Units of CPT codes. It is important to note that the actual impact on individual physician practices will depend on the mix of services the practice provides.
ASCO strongly opposes provisions in the 2019 Medicare Physician Fee Schedule (MPFS) proposed rule that could significantly cut cancer care resources that are needed to provide high-quality care to individuals with cancer
The Centers for Medicare & Medicaid Services (CMS) is advancing the Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI) Demonstration proposal to a public comment period and consideration for formal approval. If approved, the demo would waive Merit-Based Incentive Payment System (MIPS) requirements for clinicians who sufficiently participate in certain Medicare Advantage (MA) plans that involve assuming greater financial risk.
The Centers for Medicare & Medicaid Services (CMS) has provided an update on their review of a 2017 Wisconsin Physician Service Insurance Corporation (WPS)—a Medicare Administrative Contractor (MAC)—local coverage decision limiting off-label prescribing.
ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to a proposed rule to revise the agency’s methods for assuring patient access to Medicaid services. In a letter to CMS Administrator Seema Verma, ASCO President Bruce Johnson, MD, FASCO, urged CMS to maintain its rule requiring states to monitor and report on beneficiary access to providers, and to ensure that final changes do not jeopardize access to care for patients with cancer. ASCO also encouraged CMS to explicitly require state assessment of access to oncologists.
ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to a Request for Information (RFI) on Direct Provider Contracting (DPC) Models published on the Center for Medicare and Medicaid Innovation’s (CMMI) website in April 2018.
On May 8, the White House submitted a rescission package to Congress, which proposes $15 billion in cuts to 38 government programs and agencies, including to the Center for Medicare and Medicaid Innovation.
ASCO joined nearly 50 medical organizations in urging the Centers for Medicare & Medicaid Services (CMS) to reduce the quality performance period under the 2018 Merit-based Incentive Payment System (MIPS) to 90 days instead of a full calendar year.
Clinicians can now use the updated Participation Lookup Tool from the Centers for Medicare & Medicaid Services (CMS) to check their 2018 eligibility for the Merit-Based Incentive Payment System (MIPS) under the Quality Payment Program (QPP). Within the online tool, clinicians can enter their National Provider Identifier (NPI) to find out whether or not they need to participate in MIPS during the 2018 performance year.